Top Companies in the Dermatology Diagnostic Devices Market

The global dermatology diagnostic devices market was valued at USD 9.6 billion in 2023, driven by the increasing prevalence of skin diseases across the globe. The market is expected to grow at a CAGR of 12.24% during the forecast period of 2024-2032, with the values likely to reach USD 26.7 billion by 2032.

Dermatology diagnostic devices help in the diagnosis and monitoring of various skin conditions. 3D imaging systems help to capture detailed, three-dimensional images of the skin whereas dermatoscopes are widely used to get magnified images of skin lesions.

The market is experiencing a rising integration of artificial intelligence into dermatology diagnostic devices to achieve optimal diagnostic accuracy. As estimated by the World Cancer Research Fund International, there were 331,722 new cases related to skin cancer in 2022 with the highest number of cases in the United States. According to the World Health Organization, around 1.8 billion people are estimated to be affected by skin conditions globally. Additionally, the American Cancer Society has estimated that nearly 100,640 new melanoma cases will be diagnosed (about 59,170 in men and 41,470 in women) in 2024. However, the condition will claim about 8,290 deaths (approximately 5,430 men and 2,860 women). Hence, the increasing burden of skin disorders, including skin cancer, psoriasis, and dermatitis, is a major factor propelling the market demand for advanced diagnostic solutions.

In January 2024, the U.S. Food and Drug Administration approved the AI-powered DermaSensor medical device which is designed to assist doctors in detecting skin cancer. It is a prescription-based, non-invasive device that has been indicated to analyse skin lesions such as melanoma, basal cell carcinoma, and/or squamous cell carcinoma in patients aged 40 and over to assist healthcare providers in decision-making. The FDA approval is poised to push healthcare providers to adopt advanced devices to diagnose patients which may further develop high demand in the market. The market is further expected to be driven by the increasing integration of advanced technologies in dermatology diagnostic devices to enable early detection of cancers and improve patient outcomes. Moreover, the expansion of specialised dermatology clinics and the growing investment in healthcare infrastructure are expected to support market growth in the coming years.

Top Companies Leading the Dermatology Diagnostic Devices Market in 2024

 
1.    Carl Zeiss Meditec AG

Multinational medical technology, Carl Zeiss Meditec AG is a Germany-based subsidiary of Carl Zeiss AG. The company is known for its advanced imaging solutions, including high-resolution microscopes and optical coherence tomography (OCT) devices.

2.    Caliber I.D. Inc.

Caliber Imaging & Diagnostics Inc., a medical device company, develops and markets point-of-care cellular imaging systems designed to diagnose skin cancer. The company is widely recognised for its clinical imaging solutions that help in the visualisation of tissue at the cellular level. Caliber I.D. boasts a robust portfolio including VivaScope, VivaNet, and VivaScan.

3.    Michelson Diagnostic Devices Limited

Based in Bromley, United Kingdom, Michelson Diagnostic Devices Limited specializes in the development of multi-beam optical coherence tomography -based products that can enable the imaging of living tissue microstructure at less than 10 µm resolution. One of its leading products is VivoSight Dx, an innovative optical coherence tomography (OCT) system.

4.    Bomtech Electronics Co.

Bomtech Electronics Co. produces a variety of medical devices, including those for dermatological diagnostics and treatment. Bomtech's focus on innovation has led to the development of advanced skin analysis systems used by dermatologists worldwide. The company continuously shows efforts to enhance device accuracy and integrate new features, providing comprehensive solutions for skin diagnostics.

5.    Canfield Scientific, Inc.

Based in New Jersey, Canfield Scientific, Inc. is a leading provider of imaging systems for dermatology. Their advanced photographic systems, including the VISIA Complexion Analysis  and IntelliStudio, are used globally for skin analysis and documentation. The company’s advancements are focused on improving image capture and analysis capabilities, aiding in better tracking and treatment of skin conditions.

6.    Illuco Corporation Ltd.

Illuco Corporation Ltd. specializes in medical imaging devices, including dermatoscopes and skin analysis tools. Their products are known for precision and reliability, assisting dermatologists in the early detection and monitoring of skin disorders. The company’s innovative product developments are integrated with AI technology to enhance diagnostic accuracy and user experience, solidifying its role as a key player in the dermatology diagnostics market.

7.    Nikon Corporation

Nikon Corporation is a global leader in imaging technology. While widely recognized for its cameras, Nikon also provides advanced imaging solutions for dermatology, including high-resolution microscopes and imaging systems. The company is putting continuous efforts into improving imaging technology for medical applications, which include significant contributions to dermatological research and diagnostics, offering enhanced visualization of skin conditions.

8.    DermoScan GmbH

DermoScan GmbH, headquartered in Regensburg, offers innovative solutions for dermatology, focusing on skin cancer diagnostics. Their software and imaging systems provide dermatologists with tools for accurate skin analysis and early detection of melanoma. The company developed an advanced AI-powered diagnostic tool that improves the accuracy and efficiency of skin assessments, solidifying its position as a leader in dermatological diagnostics.